Cefcapene pivoxil hydrochloride tablets (Flomox) should be used under the guidance of a physician in accordance with standard practice, and the treatment plan should be determined based on the type of infection, pathogen susceptibility, and the patient's specific condition. Patients should not adjust the dosage on their own or discontinue the medication prematurely, so as not to compromise antibacterial efficacy or increase the risk of resistance.

Precautions for Cefcapene pivoxil hydrochloride tablets (Flomox)

1. Important basic precautions

Prevention of resistance: When using cefcapene pivoxil hydrochloride tablets, in principle, bacterial susceptibility should be confirmed, and the duration of administration should be kept to the minimum necessary for treatment.

Risk of shock: A thorough medical history, including allergy history, should be obtained before use.

Renal function monitoring: Renal function should be checked periodically to watch for acute kidney injury.

Hematologic system monitoring: Blood tests should be performed regularly to watch for agranulocytosis, thrombocytopenia, and hemolytic anemia.

Hepatic function monitoring: Liver function should be checked periodically to watch for fulminant hepatitis, hepatic dysfunction, and jaundice.

2. Precautions for patients with specific backgrounds

History of cephalosporin allergy: Administration is not recommended unless therapeutically necessary.

History of penicillin allergy, allergic diathesis (asthma, rash, urticaria, etc.): Administer with caution.

Patients with insufficient oral intake or poor general condition: Close observation is required, as symptoms of vitamin K deficiency may occur.

Renal impairment: For patients with renal failure or severe renal impairment (creatinine clearance ≤40 mL/min), the dose should be reduced or the dosing interval should be prolonged to prevent persistently high blood concentrations.

Pregnant women: Use only when the therapeutic benefit outweighs the potential risk. It has been reported that the use of antibiotics containing a pivoxil group in late pregnancy may cause hypocarnitinemia in both the mother and the neonate.

Children: Attention should be paid to decreased carnitine levels. If congenital carnitine metabolism disorder is diagnosed, use is prohibited. It has been reported that the use of antibiotics containing a pivoxil group in children (especially infants) may cause hypocarnitinemic hypoglycemia.

Elderly patients: Cefcapene pivoxil hydrochloride tablets are mainly excreted via the kidneys. Physiological functions are generally reduced in elderly patients, which may prolong the drug half-life. The patient's condition should be closely monitored, and dosage and dosing interval should be carefully adjusted.